Pharmaceuticals Company Announces Confirmation Study Approval For Type 1 Diabetes Treatment
Biodexa Pharmaceuticals Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada.
Disclaimer: The following article provides detailed information about an ongoing clinical study and should be interpreted within the scope of the provided data and scientific context. It is not intended for commercial use or promotional purposes.
Real-time information is available daily at https://stockregion.net